335 related articles for article (PubMed ID: 24764662)
1. Multimodal imaging evaluation in staging of rectal cancer.
Heo SH; Kim JW; Shin SS; Jeong YY; Kang HK
World J Gastroenterol; 2014 Apr; 20(15):4244-55. PubMed ID: 24764662
[TBL] [Abstract][Full Text] [Related]
2. Current trends in staging rectal cancer.
Samee A; Selvasekar CR
World J Gastroenterol; 2011 Feb; 17(7):828-34. PubMed ID: 21412492
[TBL] [Abstract][Full Text] [Related]
3. The accuracy of endorectal ultrasonography and high-resolution magnetic resonance imaging for restaging rectal cancer after neoadjuvant chemoradiotherapy.
Cote A; Florin FG; Mois E; Elisei R; Badea R; Mare C; Hajjar NA; Iancu C; Lebovici A
Ann Ital Chir; 2018; 89():168-176. PubMed ID: 29848812
[TBL] [Abstract][Full Text] [Related]
4. The Value of Restaging With Chest and Abdominal CT/MRI Scan After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
Liu GC; Zhang X; Xie E; An X; Cai PQ; Zhu Y; Tang JH; Kong LH; Lin JZ; Pan ZZ; Ding PR
Medicine (Baltimore); 2015 Nov; 94(47):e2074. PubMed ID: 26632714
[TBL] [Abstract][Full Text] [Related]
5. Optimal Imaging Strategies for Rectal Cancer Staging and Ongoing Management.
Balyasnikova S; Brown G
Curr Treat Options Oncol; 2016 Jun; 17(6):32. PubMed ID: 27255100
[TBL] [Abstract][Full Text] [Related]
6. Adverse features on rectal MRI identify a high-risk group that may benefit from more intensive preoperative staging and treatment.
Hunter CJ; Garant A; Vuong T; Artho G; Lisbona R; Tekkis P; Abulafi M; Brown G
Ann Surg Oncol; 2012 Apr; 19(4):1199-205. PubMed ID: 21913017
[TBL] [Abstract][Full Text] [Related]
7. The potential predictive value of MRI and PET-CT in mucinous and nonmucinous rectal cancer to identify patients at high risk of metastatic disease.
Barbaro B; Leccisotti L; Vecchio FM; Di Matteo M; Serra T; Salsano M; Poscia A; Coco C; Persiani R; Alfieri S; Gambacorta MA; Valentini V; Giordano A; Bonomo L
Br J Radiol; 2017 Jan; 90(1069):20150836. PubMed ID: 27845566
[TBL] [Abstract][Full Text] [Related]
8. 18F-FDG PET/MRI for Rectal Cancer TNM Restaging After Preoperative Chemoradiotherapy: Initial Experience.
Crimì F; Spolverato G; Lacognata C; Garieri M; Cecchin D; Urso ED; Zucchetta P; Pucciarelli S; Pomerri F
Dis Colon Rectum; 2020 Mar; 63(3):310-318. PubMed ID: 31842163
[TBL] [Abstract][Full Text] [Related]
9. Rectal cancer: primary staging and assessment after chemoradiotherapy.
Evans J; Patel U; Brown G
Semin Radiat Oncol; 2011 Jul; 21(3):169-77. PubMed ID: 21645861
[TBL] [Abstract][Full Text] [Related]
10. [Application of magnetic resonance in "non-operative treatment" strategy for rectal cancer].
Wang Y; Chen G
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jun; 20(6):630-634. PubMed ID: 28643307
[TBL] [Abstract][Full Text] [Related]
11. Relative Value of Restaging MRI, CT, and FDG-PET Scan After Preoperative Chemoradiation for Rectal Cancer.
Schneider DA; Akhurst TJ; Ngan SY; Warrier SK; Michael M; Lynch AC; Te Marvelde L; Heriot AG
Dis Colon Rectum; 2016 Mar; 59(3):179-86. PubMed ID: 26855391
[TBL] [Abstract][Full Text] [Related]
12. MRI for Rectal Cancer Primary Staging and Restaging After Neoadjuvant Chemoradiation Therapy: How to Do It During Daily Clinical Practice.
Cianci R; Cristel G; Agostini A; Ambrosini R; Calistri L; Petralia G; Colagrande S
Eur J Radiol; 2020 Oct; 131():109238. PubMed ID: 32905955
[TBL] [Abstract][Full Text] [Related]
13. Value of diffusion-weighted imaging in the detection of viable tumour after neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer: comparison with T2 weighted and PET/CT imaging.
Song I; Kim SH; Lee SJ; Choi JY; Kim MJ; Rhim H
Br J Radiol; 2012 May; 85(1013):577-86. PubMed ID: 21343320
[TBL] [Abstract][Full Text] [Related]
14. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
[No Abstract] [Full Text] [Related]
15. Is diffusion-weighted MRI superior to FDG-PET or FDG-PET/CT in evaluating and predicting pathological response to preoperative neoadjuvant therapy in patients with rectal cancer?
Li YL; Wu LM; Chen XX; Delproposto Z; Hu JN; Xu JR
J Dig Dis; 2014 Oct; 15(10):525-37. PubMed ID: 25060294
[TBL] [Abstract][Full Text] [Related]
16. Comparative study between endoscopic ultrasonography and positron emission tomography-computed tomography in staging patients with esophageal squamous cell carcinoma.
Yen TJ; Chung CS; Wu YW; Yen RF; Cheng MF; Lee JM; Hsu CH; Chang YL; Wang HP
Dis Esophagus; 2012 Jan; 25(1):40-7. PubMed ID: 21595776
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of MRI and 18F-FDG PET/CT for restaging after preoperative concurrent chemoradiotherapy for rectal cancer.
Cho YB; Chun HK; Kim MJ; Choi JY; Park CM; Kim BT; Lee SJ; Yun SH; Kim HC; Lee WY
World J Surg; 2009 Dec; 33(12):2688-94. PubMed ID: 19823904
[TBL] [Abstract][Full Text] [Related]
18. How reliable is current imaging in restaging rectal cancer after neoadjuvant therapy?
De Nardi P; Carvello M
World J Gastroenterol; 2013 Sep; 19(36):5964-72. PubMed ID: 24106396
[TBL] [Abstract][Full Text] [Related]
19. Preoperative imaging staging of rectal cancer.
Karantanas AH; Yarmenitis S; Papanikolaou N; Gourtsoyiannis N
Dig Dis; 2007; 25(1):20-32. PubMed ID: 17384505
[TBL] [Abstract][Full Text] [Related]
20. Factors affecting the restaging accuracy of magnetic resonance imaging after preoperative chemoradiation in patients with rectal cancer.
Kim IY; Cha SW; Ahn JH; Kim YW
Eur J Surg Oncol; 2015 Apr; 41(4):493-8. PubMed ID: 25648465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
